US2018104229A1PendingUtilityA1

Method of Treating Skin Disorders

67
Assignee: MYMD PHARMACEUTICALS INCPriority: Mar 31, 2015Filed: Dec 14, 2017Published: Apr 19, 2018
Est. expiryMar 31, 2035(~8.7 yrs left)· nominal 20-yr term from priority
Inventors:Jonnie R. Williams
A61P 37/08A61P 31/22A61P 31/20A61P 31/18A61P 31/16A61P 31/12A61P 31/00A61P 27/16A61P 27/02A61P 25/18A61P 25/16A61P 25/14A61P 25/06A61P 21/02A61P 21/00A61P 19/10A61P 19/04A61P 19/00A61P 17/06A61P 17/02A61P 15/02A61P 15/00A61P 13/10A61P 13/02A61P 11/08A61P 11/04A61P 11/02A61P 9/12A61P 9/10A61P 9/04A61P 9/00A61P 7/06A61P 7/00A61P 3/00A61P 1/18A61P 1/04A61K 31/4439A61P 25/28A61P 9/14A61P 31/06A61P 11/06A61P 1/02A61P 17/00A61P 17/10A61P 13/12A61P 3/10A61P 37/06A61P 37/02A61P 35/00A61P 19/08A61P 19/02A61P 11/00A61P 3/04A61P 1/16A61P 1/00A61P 29/00A61P 25/00C07K 14/4747A61K 8/4926A61K 31/465A61P 3/08Y02A50/30
67
PatentIndex Score
0
Cited by
0
References
0
Claims

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A method of treating a skin disorder comprises administering to an individual in need thereof a pharmaceutical composition containing a therapeutically effective amount of isomyosmine or a pharmaceutically acceptable salt thereof. 
     
     
         2 . The method of  claim 1 , wherein the skin disorder is acne. 
     
     
         3 . The method of  claim 2 , wherein the skin disorder is acne vulgaris. 
     
     
         4 . The method of  claim 1 , wherein the skin disorder is bullous phemigoid. 
     
     
         5 . The method of  claim 1 , wherein the skin disorder is dermatitis. 
     
     
         6 . The method of  claim 5 , wherein the skin disorder is selected from the group consisting of atopic dermatitis, chronic actinic dermatitis, dermatitis herpetiformis, statis dermatitis, seborrhoeic dermatitis, and neurodermatitis. 
     
     
         7 . The method of  claim 1 , wherein the skin disorder is eczema. 
     
     
         8 . The method of  claim 7 , wherein the skin disorder is selected from the group consisting of atopic eczema, discoid eczema, venous eczema, contact eczema, and xerotic eczema, and autoeczematization. 
     
     
         9 . The method of  claim 1 , wherein the skin disorder is dyshidrosis. 
     
     
         10 . The method of  claim 1 , wherein the skin disorder is hidradenitis suppurativa. 
     
     
         11 . The method of  claim 1 , wherein the skin disorder is lichen planus. 
     
     
         12 . The method of  claim 1 , wherein the skin disorder is psoriasis. 
     
     
         13 . The method of  claim 12 , wherein the skin disorder is plaque psoriasis. 
     
     
         14 . The method of  claim 1 , wherein the skin disorder is inverse psoriasis. 
     
     
         15 . The method of  claim 1 , wherein the skin disorder is pustular psoriasis. 
     
     
         16 . The method of  claim 1 , wherein the skin disorder is erythrodermis psoriasis. 
     
     
         17 . The method of  claim 1 , wherein the skin disorder is selected from the group consisting of nail psoriasis, guttate psoriasis, scalp psoriasis, and psoriatic arthritis. 
     
     
         18 . The method of  claim 1 , wherein the skin disorder is rosacea. 
     
     
         19 . The method of  claim 1 , wherein the skin disorder is scleroderma. 
     
     
         20 . The method of  claim 1 , wherein the skin disorder is morphea.

Join the waitlist — get patent alerts

Track US2018104229A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.